THOMAS RUMBLE: Open Payments
NPI 1306823323 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 18 payments from 7 companies in 2025. Trend: 2023 $423 · 2024 $359 · 2025 $407
Food & beverage: $319Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $164 |
| Teva Pharmaceuticals USA, Inc. | 2 | $105 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
Products named: INVEGA SUSTENNA, FANAPT, ARISTADA, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, REXULTI.
Industry payments across GA — which companies pay providers there.
